Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Meningococcal Vaccine Market, by Vaccine Serotype, 2018-2027 (USD Billion)
1.2.2. Meningococcal Vaccine Market, by Vaccine Type, 2018-2027 (USD Billion)
1.2.3. Meningococcal Vaccine Market, by End Users, 2018-2027 (USD Billion
1.2.4. Meningococcal Vaccine Market, By Region, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Meningococcal Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Meningococcal Vaccine Market Dynamics
3.1. Meningococcal Vaccine Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Meningococcal Vaccine Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.1. Global Meningococcal Vaccine Market, by Vaccine Serotype
4.2. Market Snapshot
4.3. Global Meningococcal Vaccine Market by Source, Performance - Potential Analysis
4.4. Global Meningococcal Vaccine Market Estimates & Forecasts by Vaccine Serotype 2018-2027 (USD Billion)
4.5. Meningococcal Vaccine Market, Sub Segment Analysis
4.5.1. MenACWY
4.5.2. MenB & Manic
4.5.3. MenC
4.5.4. MenA
4.5.5. MenAC
Chapter 5. Global Meningococcal Vaccine Market, by Vaccine Type
5.1. Market Snapshot
5.2. Global Meningococcal Vaccine Market by Source, Performance - Potential Analysis
5.3. Global Meningococcal Vaccine Market Estimates & Forecasts by Vaccine Type 2018-2027 (USD Billion)
5.4. Meningococcal Vaccine Market, Sub Segment Analysis
5.4.1. Conjugate
5.4.2. Polysaccharide
5.4.3. Subcapsular
Chapter 6. Global Meningococcal Vaccine Market, by End Users
6.1. Market Snapshot
6.2. Global Meningococcal Vaccine Market by Source, Performance - Potential Analysis
6.3. Global Meningococcal Vaccine Market Estimates & Forecasts by End Users 2018-2027 (USD Billion)
6.4. Meningococcal Vaccine Market, Sub Segment Analysis
6.4.1. Paediatric
6.4.2. Adult
6.4.3. Travelers
Chapter 7. Global Meningococcal Vaccine Market, Regional Analysis
7.1. Meningococcal Vaccine Market, Regional Market Snapshot
7.2. North America Meningococcal Vaccine Market
7.2.1. U.S. Meningococcal Vaccine Market
7.2.1.1. Vaccine Serotype breakdown estimates & forecasts, 2018-2027
7.2.1.2. Vaccine Type breakdown estimates & forecasts, 2018-2027
7.2.1.3. End Users breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Meningococcal Vaccine Market
7.3. Europe Meningococcal Vaccine Market Snapshot
7.3.1. U.K. Meningococcal Vaccine Market
7.3.2. Germany Meningococcal Vaccine Market
7.3.3. France Meningococcal Vaccine Market
7.3.4. Spain Meningococcal Vaccine Market
7.3.5. Italy Meningococcal Vaccine Market
7.3.6. Rest of Europe Meningococcal Vaccine Market
7.4. Asia-Pacific Meningococcal Vaccine Market Snapshot
7.4.1. China Meningococcal Vaccine Market
7.4.2. India Meningococcal Vaccine Market
7.4.3. Japan Meningococcal Vaccine Market
7.4.4. Australia Meningococcal Vaccine Market
7.5. Latin America Meningococcal Vaccine Market Snapshot
7.6. Rest of The World Meningococcal Vaccine Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profile
8.2.1. Bio-Manguinhos
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bio-Med Pvt. Limited
8.2.3. Chongqing Zhifei Biological Products Co., Ltd.
8.2.4. GlaxoSmithKline Plc
8.2.5. Hualan Biological Engineering Inc.
8.2.6. Incepta Pharmaceuticals Ltd.
8.2.7. Pfizer Inc.
8.2.8. Sanofi S.A
8.2.9. Serum institute of India Pvt. Ltd
8.2.10. Walvax Biotechnology Co., Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption